Innate Pharma S.A.
IPHYF
$1.45
-$0.31-17.61%
OTC PK
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.36% | 2.55% | -5.78% | -1.66% | -24.74% |
Total Receivables | -72.35% | -72.03% | 55.00% | 61.76% | 22.56% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -11.26% | -10.22% | 26.03% | 31.53% | -5.76% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -7.75% | -6.67% | 31.55% | 37.29% | 12.17% |
Total Current Assets | -24.18% | -23.29% | 9.48% | 14.25% | -12.19% |
|
|||||
Total Current Assets | -24.18% | -23.29% | 9.48% | 14.25% | -12.19% |
Net Property, Plant & Equipment | -22.31% | -21.40% | -23.45% | -20.11% | -20.64% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -87.07% | -86.91% | -72.35% | -71.14% | -97.82% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 118.51% | 121.07% | -10.93% | -7.05% | -47.12% |
Total Assets | -25.30% | -24.42% | -8.35% | -4.35% | -25.87% |
|
|||||
Total Accounts Payable | -12.96% | -11.94% | -35.16% | -32.33% | -20.26% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 64.26% | 66.19% | 339.69% | 358.86% | -81.94% |
Total Finance Division Other Current Liabilities | -10.24% | -9.19% | -10.48% | -6.58% | -21.24% |
Total Other Current Liabilities | -10.24% | -9.19% | -10.48% | -6.58% | -21.24% |
Total Current Liabilities | -0.40% | 0.77% | -0.83% | 3.50% | -46.53% |
|
|||||
Total Current Liabilities | -0.40% | 0.77% | -0.83% | 3.50% | -46.53% |
Long-Term Debt | -25.52% | -24.65% | -18.68% | -15.14% | 234.34% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -68.99% | -68.63% | -70.33% | -69.04% | -67.19% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -16.67% | -15.69% | -11.65% | -7.79% | -8.71% |
Total Liabilities | -14.70% | -13.70% | -10.99% | -7.10% | -10.15% |
|
|||||
Common Stock & APIC | -0.66% | 0.51% | 4.68% | 9.25% | 5.37% |
Retained Earnings | -8.02% | -9.29% | -5.49% | -10.09% | -29.04% |
Treasury Stock & Other | -67.19% | -66.81% | -37.50% | -34.77% | 289.19% |
Total Common Equity | -51.16% | -50.58% | -0.87% | 3.45% | -48.06% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -51.16% | -50.58% | -0.87% | 3.45% | -48.06% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -51.16% | -50.58% | -0.87% | 3.45% | -48.06% |
|